• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

  • About
    • General Information
    • Disease Research
    • Training & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti Aging Study
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Osteoarthritis
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Ways to Give
    • Tax Credit
    • Planned Giving
    • Contact Philanthropy
Home - OMRF News - Archives for scientist-news

scientist-news

OMRF brain tumor drug receives rare disease designations from the FDA

September 2, 2020

The drug treats fast-growing, deadly brain cancers with no effective treatment.

Filed Under: News, Technology Ventures News Tagged With: 007, administration, approval, bob, Bob Floyd, brain cancer, cancer, center, childhood, diffuse intrinsic pontine glioma, dipg, drug, FDA, Floyd, glioblastoma, glioma, Oblato, Oklahoma Medical Research Foundation, okn, OKN-007, OKN007, OMRF, OUHSC, pediatric, rare pediatric disease designation, Rheal, robert, rpdd, scientist-news, stephenson, Towner

OMRF receives $2.2 million to study brain cells

August 25, 2020

The National Institutes of Health has awarded OMRF scientist Tommy Lewis $2.2 million to study the inner workings of brain cells.

Filed Under: News Tagged With: aging, alzheimers, brain, cells, degeneration, dementia, disease, funding, grant, Holly, lab, Lewis, mira, mitochondiria, National Institutes of Health, neurodegeneration, news, newsok, NIH, OKC, Oklahoma, r35, research, science, scientist-news, Tommy, van remmen

OMRF finds clues to reversing heart dysfunction in older adults

August 20, 2020

The risk of heart failure increases as we age. OMRF is investigating why — and whether it can be stopped.

Filed Under: News Tagged With: aging, Ann, cardiovascular, cell, Chiao, disease, dysfunction, elderly, failure, heart, medical, mitochondria, news, newsok, OKC, Oklahoma, Oklahoma Medical Research Foundation, oklahoman, old, OMRF, pathway, research, scientist-news, target, therapy

OMRF scientists discover potential target for lymphedema therapy

August 18, 2020

A recent discovery by scientists at OMRF could aid in the development of potential therapies for lymphedema.

Filed Under: News Tagged With: biology, cancer, cardiovascular, disease, drug, intervention, jci insight, journal, lymphatic, lymphedema, news, newsok, OKC, Oklahoma Medical Research Foundation, OMRF, radiation, Sathish, scientist-news, Srinivasan, surgery, target, therapeutic, therapy, vascular

Protecting Oklahomans From the Virus

New OMRF grant to study Covid-19 in state’s different ethnic populations

A Battle That Never Ends

Renita Lewis fights lupus, which takes an outsized toll on African Americans.

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 78
  • Page 79
  • Page 80
  • Page 81
  • Page 82
  • Interim pages omitted …
  • Page 195
  • Go to Next Page »

Before Footer

Equal Opportunity Employer

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Ethics Point
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Ethics Point
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayTop Workplace